Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome
- 18 September 2004
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 100 (1) , 41-52
- https://doi.org/10.1016/j.jconrel.2004.07.033
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugateBioorganic & Medicinal Chemistry Letters, 2004
- Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicinJournal of Controlled Release, 2003
- Development of Fab′ fragments of anti-GD2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastomaCancer Letters, 2003
- Minimizing Long-Term Tumor Burden: The Logic for Metronomic Chemotherapeutic Dosing and its Antiangiogenic BasisJournal of Theoretical Biology, 2003
- Anti‐neovascular therapy by liposomal DPP‐CNDAC targeted to angiogenic vesselsFEBS Letters, 2002
- Anti-neovascular therapy using novel peptides homing to angiogenic vesselsOncogene, 2002
- Genes Expressed in Human Tumor EndotheliumScience, 2000
- Liposomal Drug FormulationsDrugs, 1998
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Doxorubicin in sterically stabilized liposomesNature, 1996